IGC Pharma (IGC) Interest Expenses (2010 - 2026)
IGC Pharma (IGC) posted quarterly Interest Expenses of $934000.0 for Q1 2026, up 641.27% year-over-year from $126000.0 in Q1 2025, and up 1082.28% quarter-over-quarter from $79000.0 in Q3 2025.
IGC Pharma (IGC) Interest Expenses (2010 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Interest Expenses for 17 consecutive years, with $934000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 641.27% year-over-year to $934000.0; the TTM figure through Mar 2026 stood at $934000.0 (up 93.9% YoY), while the FY2026 annual figure was $934000.0, up 118.74% from the prior year.
- Interest Expenses rose to $934000.0 in Q1 2026 per IGC's latest filing, from $79000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $934000.0 in Q1 2026 and bottomed at $76000.0 in Q4 2022.
- Historically, Interest Expenses has averaged $178106.2 across 5 years, with a median of $110950.0 in 2023.
- On a YoY basis, Interest Expenses climbed as much as 1396.55% in 2022 and fell as far as 84.62% in 2022.
- IGC Pharma's Interest Expenses stood at $76000.0 in 2022, then jumped by 42.11% to $108000.0 in 2023, then dropped by 26.85% to $79000.0 in 2024, then changed by 0.0% to $79000.0 in 2025, then surged by 1082.28% to $934000.0 in 2026.
- Business Quant data shows IGC's Interest Expenses at $934000.0 in Q1 2026, $79000.0 in Q3 2025, and $79000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 20.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 93.62 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -4.89 Mn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 934,000.00 |
| Mar 31, 2026 | 934,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 79,000.00 |
| Mar 31, 2025 | 126,000.00 |
| Mar 31, 2025 | 126,000.00 |
| Dec 31, 2024 | 79,000.00 |
| Dec 31, 2024 | 79,000.00 |
| Sep 30, 2024 | 118,000.00 |
| Sep 30, 2024 | 118,000.00 |
| Jun 30, 2024 | 117,000.00 |
| Jun 30, 2024 | 117,000.00 |
| Mar 31, 2024 | 136,000.00 |
| Mar 31, 2024 | 136,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Sep 30, 2023 | 107,000.00 |
| Sep 30, 2023 | 107,000.00 |